Recently, the US stock market has been full of highlights. TSMC has repeatedly hit new highs, and management's attitude is very firm—AI demand is far from reaching its ceiling. This statement directly boosted the entire chip sector. The chip index also hit a new high.

Financial stocks are also not to be outdone. As market risk appetite recovers, bank stocks have rebounded collectively, and investor sentiment has significantly improved. However, there is some disappointing news from the pharmaceutical sector—Liraglutide's approval for weight loss has been delayed, which may affect future expectations.

Also worth noting are geopolitical developments. Under the US-Taiwan trade agreement framework, long-term investment has reached $50 billion, and tariffs have reportedly been negotiated down to 15%, which is a positive for the industry chain.

But there are also challenges behind the scenes. The rising costs due to increased storage chip prices are accumulating, and the production costs of the next-generation iPhone may be affected. This indicates that while the chip industry chain is booming, cost management pressures are also increasing.